Biocryst Pharmaceuticals Inc (BCRX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
RA Capital Management

Peter Kolchinsky

15,827,186 $150,674,811 1.6%
2.
Deerfield Management

James E. Flynn

15,038,000 $143,161,760 +5% 1.69%
3.
Perceptive Advisors

Joseph Edelman

7,434,033 $70,771,994 +136% 1.38%
4. 7,025,000 $66,878,000 +213% 1.87%
5.
Two Sigma Advisors

John Overdeck And David Siegel

6,392,628 $60,857,819 +57% 0.05%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$6.36 7,861 $49,995.96 44,951 2024-05-30 Filing
$6.40 2,500 $16,000.00 2,500 2024-05-24 Filing
$6.38 5,000 $31,900.00 86,818 2024-05-20 Filing
$6.25 15,000 $93,750.00 66,997 2024-05-20 Filing
$5.57 36,300 $202,191.00 266,744 2024-05-14 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$8.97 11,180 $100,284.60 31,252 2026-05-18 Filing
$9.54 62,500 $596,250.00 400,703 2026-05-13 Filing
$10.11 49,933 $504,822.63 65,352 2026-03-20 Filing
$9.15 150,000 $1,372,500.00 400,703 2026-03-16 Filing
$7.65 21,773 $166,563.45 398,751 2025-12-22 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 22,650,988 $215,637,401 0%
2. 12,208,360 $116,223,587 0%
3. 11,244,625 $107,048,830 0%
4. 11,135,762 $106,012,454 0%
5. 11,020,968 $104,919,615 3%
News See All